What do these growing trends mean for the industry at large? As a patent or research professional, you’re invited to hear Dr. Rose Hughes, European Patent Attorney at AstraZeneca, and Dr. Caroline Peel, Head of IP and Standards Content at Clarivate Analytics, discuss the trends shaping the biosequence technology landscape.
The 2020 budgeting season is upon us and organizations everywhere are reviewing costs, resources and business priorities as they begin to plan for next year. For IP teams, both in in-house and within law firms, much of that assessment includes aligning filing strategies to business plans and client demand, recruiting and sourcing specialized talent and assessing operational infrastructure to see where it’s impeding productivity and incurring unnecessary costs.
As a patent or research professional listen to Dr. Joakim Isaksson, Business Process Owner for IP Analysis from Philips and Medha Rolvering, Global Head of Intellectual Property at Software AG discuss their views on the current industry challenges and the growing importance of patent intelligence in driving company growth.
Also, see a preview into Derwent’s new solutions that will change the way you search, browse and analyze patent information.
The impact of 5G technology will forever change industry dynamics, both inside and outside of telecommunications. Cars, bridges, buildings, roads, doorbells, fridges, drones, and everything in between—the explosion in the industrial applicability of 5G and the emergence of IP rights have yet to be fully understood and are anticipated to create complex licensing issues and opportunities.
Gene Quinn discusses the various patent prosecution sourcing models available today, their strengths and weaknesses, and how a thoughtful, coordinated approach to preparation and prosecution of patent applications can stretch budgets without reducing quality. Joining Gene is Donato Pasquariello, Senior Patent Attorney for Ericsson, Jeff Waters, Partner with Cantor Colburn, Brad Lawrence, Partner with Cantor Colburn and Richard Kolar, Head of Services for Derwent, a Clarivate Analytics company.
The advent of 5G will impact the way society connects and exploits connectivity, extending mobile data from simple phones to devices of every flavor—cars, bridges, buildings, roads, doorbells, fridges, drones—indeed, anything that either provides or benefits from data. But how well do you understand 5G and will your industry or your organization be impacted?
In this webinar, our panel of experts lay out the blockchain patent landscape and discuss the issues around blockchain patenting and the potential impact on different technology areas, including the patent system itself.
Join Gene Quinn, President and CEO of IPWatchdog, Inc, on Thursday, April 4, 2019, at 12 pm (noon) EDT, for an informative discussion on the all-important topic of information disclosure practices and requirements. Joining Gene will be Jeffrey Waters, Partner Cantor Colburn, and Michael Rau, Director IP Technical Services at Clarivate Analytics.
Malpractice concerns for patent practitioners are on the rise. As patents become more valuable and the intricacies of patent practice only continue to grow, the opportunity for mistakes with severe consequences are escalating. There is no substitute for being prepared, highly organized and having systems and policies in place to deal with a malpractice event.
As a follow-up to the Derwent Top 100 Global Innovators 2018-19 report, we invite you to a webinar featuring notable speakers from Microsoft, Dow, and 3M. The discussion will focus on the ways these industry leaders push boundaries to bring new ideas to market and foster a culture of innovation, and how IP and R&D teams can work together to drive commercial success.
This webinar is essential for global intellectual property owners looking to understand the key challenges and opportunities when innovating in the region. Common questions around the integration and analysis of Chinese patent data in the search process will be answered during this action-packed session.
In this panel talk, we will discuss an analysis on Cannabinoids patent filings which will soon be published by Derwent as a case study; using our research as a framework for a wider discussion. Cannabinoids are an active innovation area for both established multi-national patent filers as well as new entrants, as the legalization and decriminalization trend for cannabinoids increases.
In this webinar, we will review new biological therapeutic approaches such as CAR-T cell therapies and the challenges they present for patent searchers. We will illustrate how new tools, such as GENESEQ on SequenceBase and Derwent Innovation, can be used to reduce the margin for error during the patent search process, greatly increasing the speed and accuracy of your search for engineered sequences and the assessment of freedom to operate and actual infringement risk.
Join Gene Quinn on Thursday, September 27, 2018, for a free webinar discussion on the important topic of streamlining the patent prosecution process and stretching a patent budget efficiently. Joining Gene will be Sherry Knowles, Principal with Knowles Intellectual Property Strategies and former Senior Vice President and Chief Patent Counsel at GlaxoSmithKline, and Stuart Recher, Vice President of IP Services for Clarivate Analytics.
This webinar will review how we at Clarivate Analytics are using AI to develop advanced search and analysis capability leveraging the power of the world’s gold standard patent database, Derwent World Patents Index, to complement the work of the professional searcher.
During 2017, 5.6 million patent documents were published globally, with almost 50% of those being in Chinese. With patent data growing in both volume and complexity, precise monitoring and data mining is critical to gain true perspective on your patent landscape.
In a recent article, “Trends in Oncology Dealmaking” published in BioPharma Dealmakers, analysts from Clarivate Analytics explored recent trends in oncology deals, and specifically immuno-oncology, which accounted for 32 of the 35 multibillion-dollar oncology licensing deals of the last five years. Join us on May 16 at 11AM EST as we discuss key findings from this article along with research from BioWorld and an insightful patent analysis based on data from the Derwent World Patents Index and the Derwent Patents Citation Index.